Skip to content

Exploration and optimization of opiate-free anesthesia in gynecological endoscopic surgery

Exploration and optimization of opiate-free anesthesia in gynecological endoscopic surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068455
Enrollment
Unknown
Registered
2023-02-20
Start date
2023-02-20
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological endoscopic surgery

Interventions

Traditional opioid group (Group O):Propofol 1.5-2mg/kg, Sufentanil 0.5µg/kg and rocuronium 0.6 mg/kg were used for induction,Propofol 2-12mg/kg/h+ Remifentanil 2-4ug/kg/h for maintenance,Postoperative
Continuous epidural anesthesia without opioids (GS group):Epidural puncture anesthesia was performed with 0.5% ropivacaine 5ml, followed by induction with propofol 1.5-2mg/kg and rocuronium 0.6 mg/kg.
No opioid general anesthesia group (OF group):Propofol 1.5-2mg/kg, rocuronium bromide 0.6 mg/kg and lidocaine 1mg/kg were used for induction.TAP was then performed using 0.25% ropivacaine 20ml.Mainten

Sponsors

The First Affiliated Hospital of University of South China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.ASA Grade I-III, female patients aged 25-65 years; 2. No mental disorders, mental disorders and other diseases 3. Body mass index: 15-32kg/m^2; 4. An elective gynecological laparoscopic hysterectomy is planned, which is expected to last 1-3 hours; 5. No history of drug abuse, drug abuse or alcohol abuse; 6. There is no contraindication of intraspinal anesthesia; 7. Can understand the purpose of the study, participate in the study voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. ASA III level or above; 2. Have serious mental illness; 3. Emergency operation; 4. Patients with poorly controlled or untreated hypertension (blood pressure above 160/100mmHg); 5. Patients with serious heart disease; 6. Combined organ resection is required; 7. Untreated and ineffective patients with hyperthyroidism; 8. Recently participated in other clinical studies. 9. Those that the researchers considered unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
VAS score;Systolic blood pressure;Diastolic blood pressure;

Secondary

MeasureTime frame
Drug use during surgery;Adverse reaction after operation;

Countries

China

Contacts

Public ContactXiaoling Hu

The First Affiliated Hospital of University of South China

16670979693@163.com+86 166 7097 9693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026